Prodia Widyahusada Tbk PT
IDX:PRDA
Relative Value
The Relative Value of one PRDA stock under the Base Case scenario is 4 214.73 IDR. Compared to the current market price of 3 080 IDR, Prodia Widyahusada Tbk PT is Undervalued by 27%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
PRDA Competitors Multiples
Prodia Widyahusada Tbk PT Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
ID |
Prodia Widyahusada Tbk PT
IDX:PRDA
|
2.9T IDR | 1.3 | 12.7 | 7.1 | 7.1 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
89.2B EUR | 0.5 | 27.1 | 9.8 | 12.9 | |
US |
Cigna Corp
NYSE:CI
|
96B USD | 0.5 | 26.4 | 9.6 | 12.7 | ||
US |
CVS Health Corp
NYSE:CVS
|
72.2B USD | 0.2 | 9.8 | 8.8 | 8.8 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17.7B USD | 1.4 | 40.6 | 12.3 | 18.5 | ||
DE |
Fresenius SE & Co KGaA
XETRA:FRE
|
15.7B EUR | 0.7 | -26.5 | 10.1 | 22.6 | ||
US |
Quest Diagnostics Inc
NYSE:DGX
|
16B USD | 1.7 | 18.9 | 11.2 | 15.2 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
11.9B EUR | 0.6 | 23.8 | 7 | 16.5 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR | 0.6 | 23.8 | 7 | 16.6 | |
US |
DaVita Inc
NYSE:DVA
|
12.3B USD | 1 | 15.1 | 8.4 | 12 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |